Mecklenburg-Vorpommern, favorably located in the north of Germany between such large-populated economic centers as Berlin, Szczecin, Copenhagen / Malmö, St. Petersburg and Hamburg, thanks to BioCon Valley’s health and life sciences cluster, has become a recognized economic and scientific center, causing growing international interest.
Beautiful beaches, unspoiled nature, tourist attractions of this only one side of Mecklenburg-Vorpommern. The other side of this region, located on the coast of the Baltic Sea, characterizes it as an important center for the health care industry and modern life sciences.
Here are the rich traditions of the universities of Greifswald and Rostock, which are among the oldest institutions of higher education in Europe.
Thanks to consistent research and development in the last decades, as well as the implementation of development-oriented science and economics policy in Mecklenburg-Western Pomerania, a vibrant research landscape has emerged, attracting many innovative companies. These firms rely on ideal framework conditions: highly professional research institutions, optimal infrastructure in numerous business creation centers, involvement in national and international cooperation networks, as well as highly qualified personnel.
The center of the healthcare industry with dynamic development and traditions
The main areas of research are biological sciences, medicine and medical technology, molecular biology, plasma physics, neurobiology and oncology, veterinary medicine, and the cultivation of cultivated plants and their use in bioeconomics. At the same time, Mecklenburg-Western Pomerania can rely on the rich traditions of advanced research. In this connection, it is necessary to mention such well-known scientific institutions as the Friedrich Leffler Institute of Veterinary Medicine, the Karlsburg Clinic, specializing in cardiology and diabetes treatment, and the Rostock Center of Competences in the Field of Restorative Medicine. This claim for excellence in research and development continues to play a decisive role in the economic development of the region.
To date, the number of enterprises engaged in life sciences has almost tripled from 45 (1996) to 120 (2013). During this period of time, there was also an almost fivefold increase in the number of personnel employed in this field - from 750 to 3,500 employees. Along with Berlin and Brandenburg, Mecklenburg-Western Pomerania is among the top three federal states with the largest number of enterprises engaged in the life sciences, in terms of population.
More than 100,000 people are employed in the healthcare industry of Mecklenburg-Vorpommern, which makes this region, in terms of population, the leader among the German federal states.
Great international interest
In order to survive, being a relatively small scientific and economic center, in a keen competition for financial resources, employees and international recognition, Mecklenburg-Vorpommern is engaged in purposeful work to expand international cooperation. The best example of successful cooperation in the field of life sciences is the ScanBalt initiative, one of the most significant European cooperation networks, consisting of representatives of the life sciences and biotechnologies. The impetus for creating the initiative in 2001 was the BioCon Valley cluster.
To date, this cooperation network covers over 2,500 enterprises operating in the field of life sciences or related industries, as well as more than 1,000 research institutions and 200 clinics in eleven countries of the Baltic region.
Russia in the spotlight
In recent years, there has been a significant expansion of cooperation, primarily with Russia and its young and dynamically developing healthcare industry.
Facilitating the exchange of experience between specialists in both countries is provided through projects such as, for example, the joint provision of telemedicine counseling services to patients with diabetes or the fight against resistant bacteria.
Since the BioCon Valley cluster has become a member of the German-Russian Union for Cooperation in
Biotechnology, numerous specific topics were found for further joint projects, the first of which are already being implemented in practice. This cooperation is in mutual interest.